Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for fatigue in advanced cancer
ACTRN12609000794202Phase 2Completed
- Sponsor
- The University of Queensland
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of methylphenidate in cancer-related fatigue (CRF), sponsored by The University of Queensland. Primary endpoint: Fatigue. Started Oct 2009; status: completed.
02
Drugs
methylphenidate
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on ACTRN12609000794202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000794202.